AlzeCure Pharma AB (FRA:AC6) Total Stockholders Equity : €3.13 Mil (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is AlzeCure Pharma AB Total Stockholders Equity?

AlzeCure Pharma AB's Total Stockholders Equity for the quarter that ended in Sep. 2024 was €3.13 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. AlzeCure Pharma AB's Book Value per Share for the quarter that ended in Sep. 2024 was €0.04. The ratio of a company's debt over equity can be used to measure how leveraged this company is. AlzeCure Pharma AB's Debt-to-Equity for the quarter that ended in Sep. 2024 was 0.00.

AlzeCure Pharma AB Total Stockholders Equity Historical Data

The historical data trend for AlzeCure Pharma AB's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AlzeCure Pharma AB Total Stockholders Equity Chart

AlzeCure Pharma AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

17.37

10.89

3.21

5.50

2.13

AlzeCure Pharma AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Stockholders Equity	Get a 7-Day Free Trial															2.83	2.13	1.23	3.49	3.13

AlzeCure Pharma AB (FRA:AC6) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

AlzeCure Pharma AB's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(3.128	-	0)	/	88.2952
	=	0.04

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

AlzeCure Pharma AB's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	3.128
	=	0.00

AlzeCure Pharma AB Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of AlzeCure Pharma AB's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

AlzeCure Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AlzeCure Pharma AB (FRA:AC6) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ALZCUR:Sweden

Address

Halsovagen 7, Huddinge, SWE, SE 141 57

Website

https://www.alzecurepharma.se

AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in drug research with a primary focus on Alzheimer's disease. The company develops several drugs within its three research platforms NeuroRestore, Alzstatin, and Painless. The company's drug candidates include; ACD440, which is in the clinical development phase for the treatment of neuropathic pain, ACD856, ACD857, ACD679, and ACD680 for the treatment of Alzheimer's disease, and ACD137 for the treatment of severe pain in conditions such as osteoarthritis.

AlzeCure Pharma AB Headlines

No Headlines